Plasmodium falciparum dhps and dhfr markers of resistance to sulfadoxine–pyrimethamine five years (2016–2020) after the implementation of seasonal malaria chemoprevention in Cameroon [version 1; peer review: 2 approved, 1 approved with reservations]

Background Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine–pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3–59 months from 2016, raising concerns whether drug pressure...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Palmer M. Netongo, Akindeh M. Nji, Peter Thelma N. Niba, Innocent M. Ali, Randolph Ngwafor, Calvino F. Tah, Germaine Ekoyol, William D. Nana, Jude D. Bigoga, Dorothy F. Ashu, Wilfried F. Mbacham, Christopher B. Tume, Pacome V. K. Tchuenkam, Jean Paul K. Chedjou, Lesley N. Ngum
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wellcome 2024-06-01
Serie:	Wellcome Open Research
Soggetti:	sulfadoxine–pyrimethamine drug resistance plasmodium falciparum chemoprevention Pfdhps Cameroon eng
Accesso online:	https://wellcomeopenresearch.org/articles/9-323/v1
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!